SPY425.10+2.50 0.59%
DIA341.98+3.20 0.94%
IXIC14,369.71+97.98 0.69%

Egypt's Eva Pharma to export COVID-19 drug remdesivir to India

05/10/2021 09:38
Egypt's Eva Pharma to export COVID-19 drug remdesivir to India

- Egypt's Eva Pharma on Monday signed an agreement to provide India with 300,000 doses of remdesivir, used in the treatment of COVID-19, the company said in a statement.

The agreement, which was signed at the Indian embassy in Cairo, is aimed at helping India combat a surge in infections which has overwhelmed the health system and held close to record daily highs on Monday.nL1N2MX05R

Eva Pharma, a generic drugmaker established in 1997, said in June 2020 it had received a licence from Gilead Sciences Inc GILD.O to make remdesivir in Egypt and distribute it in 127 countries.

The drug targets moderate to severe cases of COVID-19 in intensive care who require oxygen.

Eva Pharma didn't disclose the deal's value.


(Reporting by Ehab Farouk; Writing by Mahmoud Mourad; Editing by Nick Macfie)

(([email protected];))